| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.590 | 26.648 | - | 21.838 | 9.364 | 58.020 | 60.578 | 59.080 | 34.697 | 23.420 |
| Total Income - EUR | 31.815 | 27.485 | - | 24.919 | 9.407 | 58.043 | 60.596 | 62.033 | 35.729 | 23.592 |
| Total Expenses - EUR | 12.371 | 11.526 | - | 9.270 | 8.700 | 5.637 | 12.346 | 11.970 | 15.752 | 23.440 |
| Gross Profit/Loss - EUR | 19.443 | 15.959 | - | 15.649 | 707 | 52.406 | 48.249 | 50.064 | 19.977 | 152 |
| Net Profit/Loss - EUR | 18.489 | 15.135 | - | 14.901 | 425 | 50.664 | 46.650 | 48.240 | 16.187 | -1.183 |
| Employees | 1 | 1 | - | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Simomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.211 | 1.251 | - | 403 | 4.103 | 3.209 | 2.522 | 2.363 | 18.496 | 43.703 |
| Current Assets | 161.518 | 100.377 | - | 50.308 | 47.039 | 100.008 | 146.886 | 88.748 | 85.856 | 62.033 |
| Inventories | 0 | 0 | - | 146 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.715 | 7.275 | - | 3.537 | 3.437 | 14.742 | 35.171 | 12.795 | 13.282 | 19.335 |
| Cash | 82.496 | 9.817 | - | 46.626 | 43.602 | 85.266 | 97.564 | 58.999 | 55.672 | 25.890 |
| Shareholders Funds | 163.347 | 15.188 | - | 51.373 | 50.803 | 95.543 | 140.073 | 48.289 | 64.329 | 62.787 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 136 | 89.817 | - | 280 | 338 | 7.675 | 9.335 | 42.822 | 40.023 | 42.949 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Simomed Srl